Van de Wouwer et al., 2006 - Google Patents
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritisVan de Wouwer et al., 2006
View HTML- Document ID
- 3346347353602734885
- Author
- Van de Wouwer M
- Plaisance S
- De Vriese A
- Waelkens E
- Collen D
- Persson J
- Daha M
- Conway E
- Publication year
- Publication venue
- Journal of Thrombosis and Haemostasis
External Links
Snippet
Background: Thrombomodulin (TM) is predominantly a vascular endothelial cell plasma membrane glycoprotein that, via distinct structural domains, interacts with multiple ligands, thereby modulating coagulation, fibrinolysis, complement activation, inflammation and cell …
- 230000000503 lectinlike 0 title abstract description 88
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van de Wouwer et al. | The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis | |
| Liu et al. | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials | |
| US11458187B2 (en) | Extracellular histones as biomarkers for prognosis and molecular targets for therapy | |
| Willis et al. | Pathogenesis of the antiphospholipid syndrome | |
| Marzeda et al. | Internal affairs: tenascin-C as a clinically relevant, endogenous driver of innate immunity | |
| Preissner et al. | Role of vitronectin and its receptors in haemostasis and vascular remodeling | |
| Miranti | Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis | |
| Muszbek et al. | Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | |
| Wyatt et al. | Extracellular chaperones and proteostasis | |
| Crawley et al. | The haemostatic role of tissue factor pathway inhibitor | |
| Miyake et al. | Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor κB and ets in a rabbit model | |
| Qing et al. | Targeted inhibition of complement activation prevents features of preeclampsia in mice | |
| Jiang et al. | Ang II–stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice | |
| US20080241165A1 (en) | Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity | |
| AU2007260872A1 (en) | Methods and compositions for treating ophthalmic conditions via modulation of megalin activity | |
| Haddox et al. | Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea | |
| Dorgalaleh et al. | von Willebrand disease | |
| JP6440036B2 (en) | Anti-β2-glycoprotein I antibody and therapeutic use thereof | |
| Beers et al. | The role of epithelial cell quality control in health and disease of the distal lung | |
| US11571461B2 (en) | Methods of use of soluble CD24 for treating lupus nephritis | |
| Leuci et al. | Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding | |
| Gando et al. | Disseminated intravascular coagulation | |
| Dagher et al. | Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait | |
| JP4256497B2 (en) | Anti-angiitis agent | |
| Elwakiel et al. | Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease |